Why LENSAR, Inc.’s (LNSR) Stock Is Up 24.50%
As of Thursday, August 13, LENSAR, Inc.’s LNSR share price has surged by 24.50%, which has investors questioning if this is right time to sell.Omar Beirat
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Commentary & Analysis
Why LENSAR, Inc.’s (LNSR) Stock Is Up 24.64%
As of Thursday, August 13, LENSAR, Inc.’s LNSR share price has surged by 24.64%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why LENSAR, Inc.’s (LNSR) Stock Is Down 5.31%
As of Thursday, August 06, LENSAR, Inc.’s LNSR share price has dipped by 5.31%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why LENSAR, Inc.’s (LNSR) Stock Is Up 5.09%
As of Monday, August 03, LENSAR, Inc.’s LNSR share price has surged by 5.09%, which has investors questioning if this is right time to sell.Michael Rose
Why LENSAR, Inc.’s (LNSR) Stock Is Down 5.47%
As of Monday, July 06, LENSAR, Inc.’s LNSR share price has dipped by 5.47%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $106.6 | $422.9 | 22% |
|
| Shares Out (Mil) | 23.0 | 41.4 | 32% |
|
| Institutional Ownership | 64.3% | 83.6% | 40% |
|
| Float (Mil) | 8.8 | 34.9 | 18% |
|
| Beta | 0.88 | 0.88 | 53% |
|
| Avg Daily Volume (000s) | 354 | 409 | 52% |
|
| Price Change (52-week) |
(30.8%) | 66.3% | 22% |
|
| Growth | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.2% | 11.9% | 77% |
|
| Net Income (5yr) | (11.6%) | (5.9%) | 28% |
|
| EPS (5yr) | 7.7% | 10.4% | 43 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.3%) | (16.2%) | 50% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | ($0.050) | $0.070 | $0.060 | |
| Month Ago EPS | ($0.220) | $1.870 | ($0.720) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | ($0.220) | $1.870 | ($0.720) | |
| Year/Year Chg | (150.0%) | (102.4%) | (112.9%) | |
| Financials | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $60 | $123 | 22% |
|
| Net Income (TTM) (Mil) | $35 | ($9) | 52% |
|
| EPS (TTM) | $1.210 | ($0.400) | 63% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($3) | 22% |
|
| Net Cash Flow (TTM) (Mil) | $6 | $1 | 53% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $22 | 19% |
|
| Enterprise Value (Q1) (Mil) | $103 | $418 | 22% |
|
| Valuation | LNSR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 7.17 | 3.13 | 85% |
|
| P/E | 16.3 | 28.1 | 40% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 2.1 | 1.7 | 69% |
|
| Ratios | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 48.3% | 58.7% | 60% |
|
| Net Margin | 57.6% | (6.9%) | 98% |
|
| ROA | 49.6% | (12.3%) | 99% |
|
| ROE | (851.7%) | (12.3%) | 0% |
|
| Liabilities to Assets | 58.8% | 46.0% | 52% |
|
| F-Score | 5 | 4 | 50% |
|
Passing Stock Screens
As of 8/21/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Magic Formula Screen
Factors: Value, Quality
Joel Greenblatt's investing approach is based on finding companies with high return on investment that are trading for less than they are worth.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
